ChemicalBook > CAS DataBase List > CYT387 2H2SO4 salt

CYT387 2H2SO4 salt

Product Name
CYT387 2H2SO4 salt
CAS No.
1056636-06-6
Chemical Name
CYT387 2H2SO4 salt
Synonyms
CYT387 sulfate;CYT-387 sulfate;CYT387 H2SO4 salt;CYT387 2H2SO4 salt;Momelotinib sulfate);CYT 387 sulfate (1:2);CYT387 (sulfate salt);CYT387 sulfate salt (CYT-387 sulfate;MOMELOTINIB SULFATE (CYT387 SULFATE SALT);CYT-387 SULFATE;CYT 387 SULFATE;MOMELOTINIB SULFATE
CBNumber
CB62624121
Molecular Formula
C23H26N6O10S2
Formula Weight
610.61674
MOL File
1056636-06-6.mol
More
Less

CYT387 2H2SO4 salt Property

storage temp. 
Store at -20°C
solubility 
Soluble in DMSO
form 
Powder
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

ChemScene
Product number
CS-0765
Product name
Momelotinibsulfate
Packaging
5mg
Price
$96
Updated
2021/12/16
ChemScene
Product number
CS-0765
Product name
Momelotinibsulfate
Packaging
10mg
Price
$126
Updated
2021/12/16
Biorbyt Ltd
Product number
orb611829
Product name
CYT387 sulfate salt
Packaging
10mg
Price
$238
Updated
2021/12/16
ChemScene
Product number
CS-0765
Product name
Momelotinibsulfate
Packaging
50mg
Price
$372
Updated
2021/12/16
Biorbyt Ltd
Product number
orb611829
Product name
CYT387 sulfate salt
Packaging
50mg
Price
$508.3
Updated
2021/12/16
More
Less

CYT387 2H2SO4 salt Chemical Properties,Usage,Production

Description

CYT387 sulfate salt is an ATP-competitive inhibitor of JAK1/JAK2 with IC50 of 11 nM/18 nM, 10-fold selectivity versus JAK3 (IC50=155 nM).

in vitro

In Vitro:CYT387 sulfate salt inhibits growth of Ba/F3-JAK2V617F and human erythroleukemia (HEL) cells (IC50=1.5 μM) or Ba/F3-MPLW515L cells (IC50=200 nM), but has considerably less activity against BCR-ABL harboring K562 cells (IC50=58 μM) and FLT3 mutation harboring MV4-11 cells (IC50=3 μM). Proliferation of parental Ba/F3 cells (Ba/F3-wt) stimulated with IL-3 is inhibited with an IC50 value of 1.4 μM, consistent with the established role of IL-3-dependent signaling in the parental cell line[1].

in vivo

In Vivo:CYT387 at twice the dose used in disease model (50 and 100 mg/kg) has little to no effect on peripheral blood counts over a period of 8 weeks. Median plasma peak concentrations are 7.1 μM with the lower dose and 32.1μM with the higher dose, with a half-life of approximately 2 hours. Trough levels at 12 hours are 10nM for the 25 mg/kg and 900nM for the 50 mg/kg dose. At day 34 after transplantation, the mean white blood cell counts and hematocrit values of the entire cohort exceeded the normal range for Balb/c mice by more than 1 SD. At this point, 6 mice are sacrificed and subjected to autopsy. In the remaining animals, treatment is initiated with 25 mg/kg CYT387, 50 mg/kg CYT387, or vehicle, administered twice daily by oral gavage (12 mice per treatment group). A rapid drop of the white cell counts is apparent in both dose cohorts as early as 6 days after initiation of treatment and a decline of the hematocrit is apparent after 20 days[2]. After oral dosing, CYT387 exhibits high plasma concentrations (Cmax= 40.4 μM; Tmax=4 h), with quantitative absolute oral bioavailability and an apparent half life of 2.4 h. The high oral bioavailability, can likely be partly ascribed to the low blood clearance of CYT387 (6.3 mL/min/kg) and therefore low susceptibility to hepatic first pass metabolism[3].

References

References:[1]. Pardanani A, et al. CYT387, a selective JAK1/JAK2 inhibitor: in vitro assessment of kinase selectivity and preclinical studies using cell lines and primary cells from polycythemia vera patients. Leukemia, 2009, 23(8), 1441-1445. [2]. Tyner JW, et al. CYT387, a novel JAK2 inhibitor, induces hematologic responses and normalizes inflammatory cytokines in murine myeloproliferative neoplasms. Blood, 2010, 115(25), 5232-5240. [3]. Burns CJ, et al. Phenylaminopyrimidines as inhibitors of Janus kinases (JAKs). Bioorg Med Chem Lett. 2009 Oct 15;19(20):5887-92.

CYT387 2H2SO4 salt Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

CYT387 2H2SO4 salt Suppliers

Haoyuan Chemexpress Co., Ltd.
Tel
021-58950125
Fax
(86) 21-58955996
Email
info@chemexpress.com
Country
China
ProdList
7553
Advantage
61
AdooQ BioScience, LLC
Tel
+1 (866) 930-6790
Fax
+1 (866) 333-9607
Email
info@adooq.com
Country
United States
ProdList
2784
Advantage
58
LETOPHARM LIMITED
Tel
+86-21-5821 5861
Fax
+86-21-5106 2861
Email
sales@letopharm.com
Country
China
ProdList
2384
Advantage
58
Intelligence Pharm Science(Shanghai) Co., Ltd.
Tel
021-57898186
Fax
021-37699262
Country
China
ProdList
449
Advantage
55
SPIRO PHARMA
Tel
Fax
-
Email
eric_feng1954@126.com
Country
China
ProdList
9254
Advantage
55
Guangzhou QiYun Biotechnology Co., Ltd.
Tel
020-61288194 61288195
Fax
020-61288700
Email
505721671@qq.com
Country
China
ProdList
3868
Advantage
58
Amadis Chemical Company Limited
Tel
571-89925085
Fax
0086-571-89925065
Email
sales@amadischem.com
Country
China
ProdList
131981
Advantage
58
Musechem
Tel
+1-800-259-7612
Fax
+1-800-259-7612
Email
info@musechem.com
Country
United States
ProdList
4662
Advantage
60
Fan De(Beijing) Biotechnology Co., Ltd.
Tel
15911056312
Email
liming@bio-fount.com
Country
China
ProdList
9730
Advantage
58
TargetMol Chemicals Inc.
Tel
+1-781-999-5354 +1-00000000000
Email
marketing@targetmol.com
Country
United States
ProdList
19892
Advantage
58

1056636-06-6, CYT387 2H2SO4 saltRelated Search:


  • CYT387 2H2SO4 salt
  • CYT387 H2SO4 salt
  • CYT387 sulfate
  • CYT-387 sulfate
  • CYT387 (sulfate salt)
  • CYT 387 sulfate (1:2)
  • N-(Cyanomethyl)-4-[2-[[4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]benzamide sulfate (1:2)
  • CYT387 sulfate salt (CYT-387 sulfate
  • Momelotinib sulfate)
  • CYT-387 SULFATE;CYT 387 SULFATE;MOMELOTINIB SULFATE
  • MOMELOTINIB SULFATE (CYT387 SULFATE SALT)
  • 1056636-06-6
  • C23H26N6O10S2
  • C23H22N6O22H2SO4